Unique Ingredient Identifier 6DC9Q167V3 is listed as a ingredient substance
| RN | 57-55-6 |
| EC | 200-338-0 |
| NCIT | C29388 |
| RXCUI | 34693 |
| PUBCHEM | 1030 |
| MF | C3H8O2 |
| SMILES | CC(O)CO |
UNII 6DC9Q167V3 PROPYLENE GLYCOL is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| AURICULAR (OTIC) | DROPS | NA |
| AURICULAR (OTIC) | SOLUTION | 94.93 % |
| AURICULAR (OTIC) | SOLUTION, DROPS | ADJPH |
| AURICULAR (OTIC) | SUSPENSION | 10 % |
| BUCCAL | FILM | 1.48 MG |
| BUCCAL | FILM, SOLUBLE | 1.02 MG |
| DENTAL | OINTMENT | NA |
| DENTAL | PASTE | NA |
| DENTAL | SOLUTION | 2 % |
| EXTRACORPOREAL | SOLUTION | 5 % |
| IM - IV | INJECTABLE | 40 % |
| IM - IV | INJECTION | 82.04 % |
| IM - IV | SOLUTION, INJECTION | 41.6 % |
| INHALATION | SOLUTION | 25 % |
| INTRAMUSCULAR | INJECTION | 41.3 %W/V |
| INTRAMUSCULAR | POWDER, FOR INJECTION SOLUTION | NA |
| INTRAMUSCULAR | SOLUTION, INJECTION | 40 %V/V |
| INTRAVENOUS | INFUSION | NA |
| INTRAVENOUS | INJECTABLE | 40 % |
| INTRAVENOUS | INJECTION | 63.4 % |
| INTRAVENOUS | INJECTION | 0.3 mL/1mL |
| INTRAVENOUS | SOLUTION, CONCENTRATE | 50.33 % |
| INTRAVENOUS | SOLUTION, INJECTION | 30.9 % |
| INTRAVENOUS INFUSION | SOLUTION, INJECTION | 503 mg/mL |
| IV(INFUSION) | INJECTABLE | 20.8 % |
| IV(INFUSION) | INJECTION | 400 MG/1ML |
| IV(INFUSION) | SOLUTION, INJECTION | 30 % |
| NASAL | SOLUTION | 12 % |
| NASAL | SPRAY, METERED | 20 % |
| OPHTHALMIC | EMULSION | 1.5 %W/V |
| OPHTHALMIC | GEL | 0.44 % |
| OPHTHALMIC | SOLUTION | 15 % |
| OPHTHALMIC | SOLUTION, DROPS | 0.75 % |
| OPHTHALMIC | SUSPENSION | 5 % |
| OPHTHALMIC | SUSPENSION, DROPS | 1 % |
| ORAL | CAPSULE | 52 MG |
| ORAL | CAPSULE, DELAYED ACTION | 0.016 MG |
| ORAL | CAPSULE, DELAYED ACTION, ENTERIC COATED | NA |
| ORAL | CAPSULE, ENTERIC COATED PELLETS | 1.7 MG |
| ORAL | CAPSULE, EXTENDED RELEASE | 0.019 MG |
| ORAL | CAPSULE, SOFT GELATIN | 148.31 MG |
| ORAL | CAPSULE, SOFT GELATIN LIQUID-FILLED | 17.7 MG |
| ORAL | CAPSULE, SUSTAINED ACTION | 14.6 MG |
| ORAL | CONCENTRATE | 700 MG/1ML |
| ORAL | DROPS | 1.25 MG/1ML |
| ORAL | LIQUID | 975 mg/10mL |
| ORAL | LIQUID | 621.6 MG/ML |
| ORAL | LIQUID | 0.15 ML/ML |
| ORAL | LIQUID, CONCENTRATE | 540 MG/1ML |
| ORAL | ORAL SOLUTION DOSAGE FORM | 250 mg/5mL |
| ORAL | POWDER | 55 MG/1SCP |
| ORAL | SOLUTION | 2475 mg/15 mL |
| ORAL | SOLUTION | 1295 mg/5 mL |
| ORAL | SOLUTION | 1017.5 MG/1ML |
| ORAL | SOLUTION | 1000 MG/5ML |
| ORAL | SOLUTION | 100 MG/ML |
| ORAL | SOLUTION, CONCENTRATE | 518 MG/1ML |
| ORAL | SOLUTION, ELIXIR | 3108 MG/15ML |
| ORAL | SOLUTION, LIQUID | 14 % |
| ORAL | SOLUTION, SYRUP | 610 MG/5ML |
| ORAL | SPRAY | 37.45 MG/1SPR |
| ORAL | SUSPENSION | 125 MG/5ML |
| ORAL | SUSPENSION | 43.46 mg/1mL |
| ORAL | SUSPENSION, EXTENDED RELEASE | 250 MG/5ML |
| ORAL | SUSPENSION, LIQUID | 250 MG/5ML |
| ORAL | SUSPENSION, SUSTAINED ACTION | 150 MG/5ML |
| ORAL | TABLET | 5.41 mg |
| ORAL | TABLET (IMMED./COMP. RELEASE), FILM COATED | 0.21 MG |
| ORAL | TABLET, COATED | 1.5 MG |
| ORAL | TABLET, CONTROLLED RELEASE | NA |
| ORAL | TABLET, DELAYED ACTION | 5.83 MG |
| ORAL | TABLET, DELAYED ACTION, ENTERIC COATED | 6.95 MG |
| ORAL | TABLET, DELAYED RELEASE | 5.97 MG |
| ORAL | TABLET, ENTERIC COATED PARTICLES | 4.3 MG |
| ORAL | TABLET, EXTENDED RELEASE | 2.44 MG |
| ORAL | TABLET, FILM COATED | 14.4 MG |
| ORAL | TABLET, SUSTAINED ACTION | 9 MG |
| ORAL | TABLET, SUSTAINED ACTION, COATED | NA |
| ORAL | TABLET, SUSTAINED ACTION, FILM COATED | 12.8 MG |
| PARENTERAL | INJECTION | 0.1 ML/1ML |
| PHOTOPHERESIS | SOLUTION | 5 % |
| RECTAL | AEROSOL, METERED | 18 % |
| RECTAL | EMULSION, AEROSOL FOAM | 47.04 % |
| RECTAL | GEL | 82.88 % |
| RECTAL | SUSPENSION | 11.3 % |
| SUBCUTANEOUS | INJECTION | 1.4 % |
| SUBCUTANEOUS | INJECTION, SOLUTION | 14 MG/1ML |
| SUBCUTANEOUS | SOLUTION, INJECTION | 0.47 % |
| SUBLINGUAL | FILM | QS |
| SUBLINGUAL | SPRAY | 0.45 % |
| TOPICAL | AEROSOL | 19.2 %W/W |
| TOPICAL | AEROSOL, FOAM | 2.1 %W/W |
| TOPICAL | AEROSOL, METERED | NA |
| TOPICAL | CREAM | 71.08 %W/W |
| TOPICAL | CREAM | 54.9 %W/W |
| TOPICAL | CREAM | 50 %W/W |
| TOPICAL | CREAM | QS |
| TOPICAL | CREAM, AUGMENTED | 30 %W/W |
| TOPICAL | EMULSION | 8 %W/W |
| TOPICAL | EMULSION, AEROSOL FOAM | 21.05 %W/W |
| TOPICAL | EMULSION, CREAM | 71.08 %W/W |
| TOPICAL | EMULSION, LOTION | 47.5 %W/W |
| TOPICAL | FILM, CONTROLLED RELEASE | 700 MG |
| TOPICAL | GEL | 98.09 %W/W |
| TOPICAL | LOTION | 47.6 %W/W |
| TOPICAL | LOTION | 47.5 %W/W |
| TOPICAL | LOTION, AUGMENTED | 30 %W/W |
| TOPICAL | OINTMENT | 45 %W/W |
| TOPICAL | OINTMENT, AUGMENTED | 65 %W/W |
| TOPICAL | PATCH | NA |
| TOPICAL | PATCH, CONTROLLED RELEASE | NA |
| TOPICAL | SHAMPOO | 3.5 %W/W |
| TOPICAL | SHAMPOO, SUSPENSION | 2 %W/W |
| TOPICAL | SOLUTION | 99.98 %W/W |
| TOPICAL | SOLUTION, LIQUID | 5 %W/W |
| TOPICAL | SPONGE | NA |
| TOPICAL | SUPPOSITORY | NA |
| TOPICAL | SUPPOSITORY, INSERT | 20 %W/W |
| TOPICAL | SUSPENSION | 5.28 %W/W |
| TOPICAL | SWAB | NA |
| TRANSDERMAL | FILM, CONTROLLED RELEASE | 58.13 MG |
| TRANSDERMAL | GEL | 20 % |
| TRANSDERMAL | GEL | 5 %W/W |
| VAGINAL | CREAM | 10 %W/W |
| VAGINAL | CREAM, EMULSION, SUSTAINED RELEASE | 20 % |
| VAGINAL | EMULSION, AEROSOL FOAM | 6.4 % |
| VAGINAL | EMULSION, CREAM | 20 % |
| VAGINAL | GEL | 3 % |
| VAGINAL | SUPPOSITORY | 252 MG |
| VAGINAL | TAMPON | 62.1 MG |